Contemporary Endothelial Genome Editing Technologies: Towards Precision Genetic Medicine for Vascular Diseases
International Journal of Molecular Sciences · 04.06.2026 · 27 (11) · 5100
DOI: 10.3390/ijms27115100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.06.2026. Verfasst von You-Yang Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Program for Lung and Vascular Biology, Section for Injury Repair and Regeneration Research, Stanley Manne Children's Research Institute, Ann & Robert…. Hauptthemen laut MEDLINE: Gene Editing, Vascular Diseases, Endothelial Cells, Precision Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, American Heart Association.
Abstract (Originalsprache)
Endothelial dysfunction is a key characteristic of many diseases, including atherosclerosis, hypertension, heart failure, stroke, cancer, acute respiratory distress syndrome (ARDS), peripheral vascular disease, coronavirus 2019 (COVID-19), and pulmonary arterial hypertension (PAH). To improve understanding of the roles of endothelial cells (ECs) in health and disease, EC-specific genome editing technologies have been developed in recent years. Therapeutic strategies that aim to restore a healthy endothelial monolayer include the inhibition of endothelial genes that cause EC injury and dysfunction and the induction or activation of endothelial genes that drive EC repair and regeneration. In this review, we describe established recombinase-mediated genetic modification technologies and emerging EC-specific genome editing technologies including viral and non-viral delivery of the CRISPR/Cas9 genome editing system, and we summarize the strengths and limitations of each technology. We then discuss possible avenues for future research, including the development of organ-specific EC genome editing technologies. In short, EC-specific genome editing technologies can be used to modulate gene expression selectively in ECs and even within a specific vascular bed and/or distinctive EC subtype, and, in doing so, greatly improve the understanding of vascular biology and help develop precision genetic medicine targeting the disease-causing vascular bed(s) to effectively treat diseases caused by vascular endothelial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Program for Lung and Vascular Biology, Section for Injury Repair and Regeneration Research, Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
- Department of Pediatrics, Division of Critical Care, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- Genetic Medicine and Nanotechnology Development Center (GeneMeNDer), Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
- Departments of Pharmacology and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- Feinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
ORCID-Profile: You-Yang Zhao
Förderung
- NHLBI NIH HHS
- NIH HHS
- American Heart Association
- National Institutes of Health
Zitieren
APA
Zhao, Y. Y., & Evans, C. E. (2026). Contemporary Endothelial Genome Editing Technologies: Towards Precision Genetic Medicine for Vascular Diseases. International Journal of Molecular Sciences, 27(11), 5100. https://doi.org/10.3390/ijms27115100
Vancouver
Zhao YY, Evans CE. Contemporary Endothelial Genome Editing Technologies: Towards Precision Genetic Medicine for Vascular Diseases. International Journal of Molecular Sciences. 2026;27(11):5100. doi:10.3390/ijms27115100
BibTeX
@article{Zhao2026,
author = {Zhao, You-Yang and Evans, Colin E},
title = {Contemporary Endothelial Genome Editing Technologies: Towards Precision Genetic Medicine for Vascular Diseases},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {5100},
doi = {10.3390/ijms27115100}
}
EUVIMED